184 related articles for article (PubMed ID: 22693581)
41. Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells.
Kozar I; Cesi G; Margue C; Philippidou D; Kreis S
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2980-2992. PubMed ID: 28408301
[TBL] [Abstract][Full Text] [Related]
42. Molecular profiling of driver events in metastatic uveal melanoma.
Karlsson J; Nilsson LM; Mitra S; Alsén S; Shelke GV; Sah VR; Forsberg EMV; Stierner U; All-Eriksson C; Einarsdottir B; Jespersen H; Ny L; Lindnér P; Larsson E; Olofsson Bagge R; Nilsson JA
Nat Commun; 2020 Apr; 11(1):1894. PubMed ID: 32313009
[TBL] [Abstract][Full Text] [Related]
43. Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for
Anbunathan H; Verstraten R; Singh AD; Harbour JW; Bowcock AM
Clin Cancer Res; 2019 Aug; 25(16):5156-5166. PubMed ID: 31227497
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1.
Thomsen H; Chattopadhyay S; Hoffmann P; Nöthen MM; Kalirai H; Coupland SE; Jonas JB; Hemminki K; Försti A
Melanoma Res; 2020 Apr; 30(2):166-172. PubMed ID: 31626034
[TBL] [Abstract][Full Text] [Related]
45. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Tímár J; Gyorffy B; Rásó E
Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
[TBL] [Abstract][Full Text] [Related]
46. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.
Ehlers JP; Worley L; Onken MD; Harbour JW
Clin Cancer Res; 2005 May; 11(10):3609-13. PubMed ID: 15897555
[TBL] [Abstract][Full Text] [Related]
47. The genetic evolution of metastatic uveal melanoma.
Shain AH; Bagger MM; Yu R; Chang D; Liu S; Vemula S; Weier JF; Wadt K; Heegaard S; Bastian BC; Kiilgaard JF
Nat Genet; 2019 Jul; 51(7):1123-1130. PubMed ID: 31253977
[TBL] [Abstract][Full Text] [Related]
48. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
Filer RS; Song JC; Char DH; Kaleta-Michaels S
Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
[TBL] [Abstract][Full Text] [Related]
49. Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.
Venza I; Visalli M; Oteri R; Cucinotta M; Teti D; Venza M
Pigment Cell Melanoma Res; 2013 Mar; 26(2):193-204. PubMed ID: 23176534
[TBL] [Abstract][Full Text] [Related]
50. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
[TBL] [Abstract][Full Text] [Related]
51. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
[TBL] [Abstract][Full Text] [Related]
52. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
53. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
54. Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Kucherlapati M
BMC Cancer; 2018 Aug; 18(1):818. PubMed ID: 30107825
[TBL] [Abstract][Full Text] [Related]
55. Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome.
Singh AD; Shields CL; Shields JA; Eagle RC; De Potter P
Ophthalmic Genet; 1995 Jun; 16(2):53-61. PubMed ID: 7493157
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of transposable elements in the medaka melanoma model.
Helmprobst F; Kneitz S; Klotz B; Naville M; Dechaud C; Volff JN; Schartl M
PLoS One; 2021; 16(10):e0251713. PubMed ID: 34705830
[TBL] [Abstract][Full Text] [Related]
57. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
58. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
[TBL] [Abstract][Full Text] [Related]
59. Emerging insights into the molecular pathogenesis of uveal melanoma.
Landreville S; Agapova OA; Harbour JW
Future Oncol; 2008 Oct; 4(5):629-36. PubMed ID: 18922120
[TBL] [Abstract][Full Text] [Related]
60. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
Mergener S; Siveke JT; Peña-Llopis S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
